Assessing Hydration Status With a Wearable Bioimpedance Sensor in Elderly Individuals
- Conditions
- Dehydration
- Interventions
- Device: Wearable bioimpedance sensor
- Registration Number
- NCT05831800
- Lead Sponsor
- Mode Sensors AS
- Brief Summary
This is a single-arm prospective study, investigating the feasibility, usability, and safety of a wearable bioimpedance sensor in elderly individuals. The sensor is applied on the upper back of the subject, and will be replaced once weekly. The study will include four phases, each interspersed by an interim analysis. Each phase will have a duration of four weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
- Age ≥ 60 years
- Known allergies or skin sensitivities to electrode hydrogel and/or acrylic-based adhesives
- Non-intact skin such as skin breakdown where the device is to be placed (upper back)
- Implantable pulse generators such as pacemakers and defibrillators
- Any medical or psychiatric condition, which in the opinion of the investigator precludes participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Wearable bioimpedance sensor Wearable bioimpedance sensor -
- Primary Outcome Measures
Name Time Method Mean use time of the wearable sensor Up to 7 days
- Secondary Outcome Measures
Name Time Method Clinical assessment of hydration status Day 1, 8, 15, 22, 29 The mean number of days the sensor provides valid measurements Up to 7 days Frequency and severity of adverse device effects Day 1-30 Stability of device measurements following weekly patch replacement Day 8, 15, 22, 29 Test-retest reliability of the investigational device will be investigated by assessing the correlation between impedance measurements (in Ohm) before and after device replacement.
Mean and standard deviation of the device output variables Up to 7 days User satisfaction Day 8, 15, 22, 29 Will be assessed using a likert scale from 1-5, where 1 represents "strongly disagree" and 5 represents "strongly agree".
Trial Locations
- Locations (1)
Tempe Helse- og velferdssenter
🇳🇴Trondheim, Norway